-- Three of Sunflower Pharmaceutical's (SHE:002737) products were provisionally selected for China's centralized volume-based procurement program for traditional medicines.
The Chinese medicine group's liver protection tablets, children's lung heat cough oral liquid/granules and digestive tablets were picked during the fourth batch of the National Traditional Chinese Medicine Procurement Alliance project, according to a Wednesday filing with the Shenzhen bourse.
Shares of the company closed 2% lower Wednesday.